FDA Clears ATS Simulus Semi-Rigid Annuloplasty Ring
October 30, 3007 - ATS Medical Inc., manufacturer and marketer of state-of-the-art cardiac surgery products and services, announced the FDA gave it clearance for the ATS Simulus Semi-Rigid Annuloplasty Ring designed for mitral valve repair.
These semi-rigid rings are the next in a series of mitral valve repair products developed and commercialized through the Company’s partnership with Genesee BioMedical. This collaboration has worked closely with cardiac surgeons to create a semi-rigid ring with the unique Flex-Zoneanterior segment. The ring respects the natural motion of the mitral annulus and its proximity to the aortic valve allowing for a safer, more physiologic valve repair. Annuloplasty rings and bands are used in those cases where repair of a patient’s heart valve is preferable to replacement of the valve.
ATS Simulus Flexible rings and bands were introduced in 2006 and employ an innovative braided polyester material that uniquely offers flexibility without elasticity.
For more information: www.atsmedical.com